Ricerca avanzata

Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2005 Settembre;47(3) > Panminerva Medica 2005 Settembre;47(3):143-55

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOPANMINERVA MEDICA

Rivista di Medicina Interna

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6

Periodicità: Trimestrale

ISSN 0031-0808

Online ISSN 1827-1898

 

Panminerva Medica 2005 Settembre;47(3):143-55

 REVIEWS

Defects in cardiomyocyte function: role of beta-adrenergic receptor dysfunction

Perrino C. 1, Esposito G. 2, Rockman H. A. 1

1 Department of Medicine Cell Biology and Molecular Genetics Duke University Medical Center, Durham, NC, USA
2 University Federico II, Naples, Italy

Heart failure is a common clinical syndrome characterized by increased levels of circulating catecholamines and extensive abnormalities in the β-adrenergic receptor (βAR) system. Interestingly, whether dampening of βAR signals is beneficial or detrimental for the failing cardiomyocyte is still controversial. In this review we will discuss a number of studies addressing the role of βAR dysfunction in the development and progression of cardiomyocyte failure, and novel possible strategies to ameliorate cardiomyocyte contractility in heart failure through the normalization of βAR signaling.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina